In the past few days, some private hospitals in Shanghai have received many phone calls to make appointments with Novo Healthcare. Recently, there have been a lot of inquiries over the phone and onli ...

Recently, Robin Lee, the founder, chairman and CEO of Baidu, said that 18% of search results have been generated by AI at Baidu's 2024 second quarter financial report conference. Baidu collaborates w ...

On the 27th, it was learned from multinational pharmaceutical company Sanofi that the company has decided to temporarily suspend the supply and sales of influenza vaccines in China. However, company ...

On August 19th, according to the official website of the National Medical Products Administration, AstraZeneca's IL-5R alpha monoclonal antibody (benralizumab) has been approved for listing in China. ...

Following the release of spy photos from domestic road tests in March this year, spy photos of NIO's third brand, codenamed "Firefly," conducting road tests in Catalonia, Spain, were recently exposed ...

With the approval of the world's first GLP-1RA weekly formulation (trade name: Novo Nordisk) developed and produced by Novo Nordisk for long-term weight management in China, pricing and commercializa ...

On May 8th, according to China Daily, Tesla proposed to land an "unmanned taxi" in China. In this regard, the Chinese government may first support its testing and demonstration in China, but has not ...

On March 26th, Fuzhou 360 Network Small Loan Co., Ltd., a subsidiary of Qifu Technology, successfully issued the first domestic exchange asset-backed securities (ABS) project that received an AAA int ...

On February 23rd, Interface News learned that multinational pharmaceutical company (MNC), Bristol Myers Squibb (BMS), has granted the sales rights of its star product, Navolizumab (commonly known as ...

Today (December 10th), the 2023 (21st) China Enterprise Leaders Annual Conference was held in Beijing. At the "AI Forum" held in the afternoon with the theme of "One Year Challenge and Outlook for Bi ...

According to reporters, Tesla's domestic sales in November were 65500 yuan, an increase of 129% compared to the previous month.

On November 8th local time, American pharmaceutical giant Lilly announced that its GLP-1R/GIPR dual target agonist, Tilposide Injection Zepbound, has been approved by the US Food and Drug Administrat ...

As Tesla's most important model, the updated version of the Tesla Model 3 officially began delivery in China on October 26th. According to Tesla China's official website, the current pick-up cycle fo ...